Publication:
Risk factors and complications of intracranial pressure monitoring with a fiberoptic device

dc.contributor.buuauthorBekar, Ahmet
dc.contributor.buuauthorDoğan, Şeref
dc.contributor.buuauthorAbaş, Faruk
dc.contributor.buuauthorCaner, Burcu
dc.contributor.buuauthorKorfalı, Gülşen
dc.contributor.buuauthorKocaeli, Hasan
dc.contributor.buuauthorYılmazlar, Selçuk
dc.contributor.buuauthorKorfalı, Ender
dc.contributor.buuauthorCaner, Burcu
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentAnestezi ve Reanimasyon Ana Bilim Dalı
dc.contributor.departmentNöroşirürji Ana Bilim Dalı
dc.contributor.orcid0000-0003-3633-7919
dc.contributor.researcheridAAI-6531-2021
dc.contributor.researcheridAAH-5070-2021
dc.contributor.scopusid7102693077
dc.contributor.scopusid6603677218
dc.contributor.scopusid8546184300
dc.contributor.scopusid25027089000
dc.contributor.scopusid6701462594
dc.contributor.scopusid6603500567
dc.contributor.scopusid6603059483
dc.contributor.scopusid7004641343
dc.date.accessioned2021-11-15T10:42:44Z
dc.date.available2021-11-15T10:42:44Z
dc.date.issued2009-02
dc.description.abstractWe prospectively investigated the complications associated with intraparenchymal intracranial pressure (ICP) monitoring using the Camino intracranial pressure device. A fiberoptic ICP monitoring transducer was implanted in 631 patients. About half of the patients (n = 303) also received an external ventricular drainage set (EVDS). The durations (mean +/- SD) of ICP monitoring in patients without and with an EVDS were 6.5 +/- 4.4 and 7.3 +/- 5.1 days, respectively. Infection occurred in 6 patients with only an ICP transducer (6/328, 1.8%) and 24 patients with an EVDS also (24/303, 7.9%). The duration of monitoring had no effect on infection, whereas the use of an EVDS for more than 9 days increased infection risk by 5.11 times. Other complications included transducer disconnection (2.37%), epidural hematoma (0.47%), contusion (0.47%), defective probe (0.31%), broken transducer (0.31%), dislocation of the fixation screw (0.15%), and intraparenchymal hematoma (0.15%). In conclusion, intraparenchymal ICP monitoring systems can be safely used in patients who either have, or are at risk of developing, increased ICP.
dc.identifier.citationBekar, A. vd. (2009). "Risk factors and complications of intracranial pressure monitoring with a fiberoptic device". Journal of Clinical Neuroscience, 16(2), 236-240.
dc.identifier.endpage240
dc.identifier.issn0967-5868
dc.identifier.issue2
dc.identifier.pubmed19071023
dc.identifier.scopus2-s2.0-58149182696
dc.identifier.startpage236
dc.identifier.urihttps://doi.org/10.1016/j.jocn.2008.02.008
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0967586808001082
dc.identifier.urihttp://hdl.handle.net/11452/22653
dc.identifier.volume16
dc.identifier.wos000264181900010
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier
dc.relation.journalJournal of Clinical Neuroscience
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectComplications
dc.subjectFiberoptic device
dc.subjectIntracranial pressure
dc.subjectMonitoring
dc.subjectBrain-tissue pressure
dc.subjectHead-injured patients
dc.subjectClinical-evaluation
dc.subjectInfectious complications
dc.subjectAggressive treatment
dc.subjectExperience
dc.subjectDuration
dc.subjectNeurosciences & neurology
dc.subject.emtreeAdolescent
dc.subject.emtreeAged
dc.subject.emtreeArticle
dc.subject.emtreeChild
dc.subject.emtreeComplication
dc.subject.emtreeControlled study
dc.subject.emtreeContusion
dc.subject.emtreeDevice infection
dc.subject.emtreeEpidural hematoma
dc.subject.emtreeFemale
dc.subject.emtreeFiber optics
dc.subject.emtreeHuman
dc.subject.emtreeInfection risk
dc.subject.emtreeIntracranial pressure monitoring
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeMedical instrumentation
dc.subject.emtreePatient safety
dc.subject.emtreePressure transducer
dc.subject.emtreePriority journal
dc.subject.emtreeRisk factor
dc.subject.emtreeTransducer
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshChild
dc.subject.meshChild, preschool
dc.subject.meshFemale
dc.subject.meshGlasgow coma scale
dc.subject.meshHumans
dc.subject.meshInfant
dc.subject.meshIntracranial hypertension
dc.subject.meshIntracranial pressure
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshMonitoring, physiologic
dc.subject.meshOptical fibers
dc.subject.meshProspective studies
dc.subject.meshRetrospective studies
dc.subject.meshRisk factors
dc.subject.meshStatistics, nonparametric
dc.subject.meshYoung adult
dc.subject.scopusVentriculostomy; Intracranial Pressure; Drain
dc.subject.wosClinical neurology
dc.subject.wosNeurosciences
dc.titleRisk factors and complications of intracranial pressure monitoring with a fiberoptic device
dc.typeArticle
dc.wos.quartileQ4 (Neurosciences)
dc.wos.quartileQ3 (Clinical neurology)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Nöroşirürji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Anestezi ve Reanimasyon Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: